Department of Food Science, Cornell University, Ithaca, New York, USA.
Department of Food Science, Cornell University, Ithaca, New York, USA
mBio. 2020 Aug 25;11(4):e01263-20. doi: 10.1128/mBio.01263-20.
Cereulide-producing members of group III (also known as emetic ) possess cereulide synthetase, a plasmid-encoded, nonribosomal peptide synthetase encoded by the gene cluster. Despite the documented risks that cereulide-producing strains pose to public health, the level of genomic diversity encompassed by emetic has never been evaluated at a whole-genome scale. Here, we employ a phylogenomic approach to characterize group III genomes which possess ( positive) alongside their closely related, -negative counterparts (i) to assess the genomic diversity encompassed by emetic and (ii) to identify potential loss and/or gain events within the evolutionary history of the high-risk and medically relevant sequence type (ST) 26 lineage often associated with emetic foodborne illness. Using all publicly available -positive group III genomes and the -negative genomes interspersed among them ( = 159), we show that emetic is not clonal; rather, multiple lineages within group III harbor cereulide-producing strains, all of which share an ancestor incapable of producing cereulide (posterior probability = 0.86 to 0.89). Members of ST 26 share an ancestor that existed circa 1748 (95% highest posterior density [HPD] interval = 1246.89 to 1915.64) and first acquired the ability to produce cereulide before 1876 (95% HPD = 1641.43 to 1946.70). Within ST 26 alone, two subsequent gain events were observed, as well as three loss events, including among isolates responsible for toxicoinfection (i.e., "diarrheal" illness). is responsible for thousands of cases of foodborne disease each year worldwide, causing two distinct forms of illness: (i) intoxication via cereulide (i.e., emetic syndrome) or (ii) toxicoinfection via multiple enterotoxins (i.e., diarrheal syndrome). Here, we show that emetic is not a clonal, homogenous unit that resulted from a single cereulide synthetase gain event followed by subsequent proliferation; rather, cereulide synthetase acquisition and loss is a dynamic, ongoing process that occurs across lineages, allowing some group III populations to oscillate between diarrheal and emetic foodborne pathogens over the course of their evolutionary histories. We also highlight the care that must be taken when selecting a reference genome for whole-genome sequencing-based investigation of emetic outbreaks, since some reference genome selections can lead to a confounding loss of resolution and potentially hinder epidemiological investigations.
产呕吐毒素的 III 组(也称为致吐)成员拥有呕吐毒素合成酶,这是一种由质粒编码的非核糖体肽合成酶,由基因簇编码。尽管有文件记录表明产呕吐毒素的菌株对公众健康构成风险,但致吐 III 组的基因组多样性从未在全基因组范围内进行过评估。在这里,我们采用系统发育基因组学方法来描述 III 组基因组,这些基因组除了携带(阳性)之外,还携带其密切相关的(阴性)对应物(i)评估致吐 III 组的基因组多样性,以及(ii)确定与高风险和医学相关的序列型(ST)26 谱系相关的进化历史中可能发生的呕吐毒素合成酶获得和/或丧失事件,该谱系通常与致吐性食源性疾病有关。使用所有公开的 III 组阳性基因组和散布其中的阴性基因组(= 159),我们表明致吐并非克隆的;相反,III 组内的多个谱系都携带产呕吐毒素的菌株,它们都拥有一个无法产生呕吐毒素的祖先(后验概率为 0.86 到 0.89)。ST 26 的成员共享一个大约存在于 1748 年的祖先(95%最高后验密度 [HPD]区间= 1246.89 到 1915.64),并在 1876 年之前首次获得产生呕吐毒素的能力(95% HPD = 1641.43 到 1946.70)。仅在 ST 26 内部,就观察到了两次随后的获得事件和三次丧失事件,包括负责毒血症感染(即“腹泻”疾病)的分离株。每年在全球范围内导致数千例食源性疾病,引起两种不同形式的疾病:(i)通过呕吐毒素(即致吐综合征)引起的中毒,或(ii)通过多种肠毒素(即腹泻综合征)引起的毒血症感染。在这里,我们表明致吐并非是由单个呕吐毒素合成酶获得事件及其随后的增殖产生的单一、同质单位;相反,呕吐毒素合成酶的获得和丧失是一个动态的、持续的过程,它发生在不同的谱系中,使一些 III 组群体在其进化过程中能够在腹泻和致吐性食源性病原体之间来回振荡。我们还强调,在基于全基因组测序的致吐爆发调查中选择参考基因组时必须谨慎,因为一些参考基因组选择可能导致分辨率降低,并可能阻碍流行病学调查。